In focus
Latest feed
Viridian Therapeutics’ LUMVOA Gets FDA Nod, Poised for Market Debut
Pfizer Shares Slip After Seagen’s Origin Cancer Drug Delivers Mixed Top‑line Results
Boehringer Ingelheim’s Survodutide Shows Promise in Late‑Stage Obesity Trials
Immunovant's Batoclimab Shakes Up Arthritis Treatment Hopes with Promising Trial Data
